TCTR20161115004招募中1 期
Programmed cell death ligand 1 expression and clinical correlation in epithelial ovarian carcinoma patients
Siriraj Research Development Fund0 个研究点目标入组 92 人开始时间: 2016年11月15日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 92
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 0 N/A (No limit)（—）
- 性别
- Female
入选标准
- •â€¢Patients who are suspected Ovarian cancer and admit for primary surgical treatment
- •â€¢Age ≥ 18 years and can use Thai and sign in consent form
排除标准
- •Final pathology is not epithelial ovarian carcinoma
研究者
相似试验
尚未招募
不适用
Expression of programmed cell death-1 (PD-1) and its ligand PD-L1 and PD-L2 as well as the enzyme indolamin 2,3-dioxygenase (IDO) in primary lymphomas of the skilymphoma of the skinC83Non-follicular lymphomaDRKS00010675niversitätsklinik FreiburgDermatologie und Venerologie40
Unknown
不适用
The Predictive Role of Programmed Death Ligand 1 (PD-L1) and Neutrophil to Lymphocyte Ratio (NLR) in Non-Small Cell Lung Cancer (NSCLC)To Define an Easy and Feasible Panel Which May be Routinely Applied to Select Patients for Immunotherapy Avoiding More Complex and Expensive MethodsNCT03816657Fondazione Ricerca Traslazionale93
Unknown
不适用
PD-L1 Expression in Advanced OsteosarcomaProgressionSurvivalNCT03582527Peking University People's Hospital50
Unknown
不适用
Assessment of PD-1 and PD-L1Tissue Expression Levels in Lichen Planus Patients: A Case-Control StudyLichen PlanusNCT04892381Cairo University60
已完成
不适用
The Role of Programmed Death Ligand -1 (Pdl-1) in Lung CancerLung CancerNCT05082636Assiut University90